 MONTRÉAL, Jan. 18, 2023 CNW Telbec Pharmascience Canada now adds PRpms-DEFERASIROX TYPE J to its product catalogue, available in 90 mg and 360 mg tablets. The 180 mg tablets will be available in a few weeks only. pms-DEFERASIROX TYPE J is used to treat chronic iron overload in: adult patients and children aged 6 years and ...... 